Thema
Journal Article
Case Reports
4
Clinical Trial, Phase III
3
Multicenter Study
3
Randomized Controlled Trial
3
9007-73-2
2
C3VX249T6L
2
COVID-19
2
Complement C5
2
Complement Inactivating Agents
2
Ferritins
2
Hemoglobins
2
Recombinant Fusion Proteins
2
Research Support, Non-U.S. Gov't
2
ravulizumab
2
(131)I-rituximab
1
131I-rituximab
1
4F4X42SYQ6
1
8W5C518302
1
9014-42-0
1
A3ULP0F556
1
AQK7UBA1LS
1
Activin Receptors, Type II
1
Antibodies, Monoclonal, Humanized
1
Antibodies, Monoclonal, Murine-Derived
1
Asia
1
BCL2 and BCL6 gene rearrangements
1
BCL2 protein, human
1
BCL6 protein, human
1
CD5 Antigens
1
Case report
1
Cerebral venous thrombosis
1
Cholecystitis
1
Complement Factor B
1
D-dimer
1
Dapsone
1
Deferasirox
1
EC 2.7.11.30
1
EC 3.2.1.22
1
EC 3.4.21.47
1
EC 3.6.4.1
1
Essential thrombocythaemia
1
GN5XU2DXKV
1
Healthcare Resource Utilization
1
Hematinics
1
Immunoglobulin Fc Fragments
1
Immunoglobulins, Intravenous
1
Inherited macrothrombocytopenia
1
Iodine-131
1
Iron Chelating Agents
1
mehr ...